Therapy: Risks associated with chronic PPI use — signal or noise?
@article{Kia2016TherapyRA, title={Therapy: Risks associated with chronic PPI use — signal or noise?}, author={L. Kia and P. Kahrilas}, journal={Nature Reviews Gastroenterology &Hepatology}, year={2016}, volume={13}, pages={253-254} }
Chronic kidney disease has joined the growing list (pneumonia, myocardial infarction, hip fracture, Clostridium difficile infections, acute interstitial nephritis, hypomagnesaemia) of putative risks associated with chronic PPI use based on results from an observational epidemiological study. However, the low hazard ratio (<1.5) makes it doubtful that this association is a causal relationship.
Tables and Topics from this paper
Paper Mentions
19 Citations
Proton pump inhibitors and risk of Clostridium difficile infection: association or causation?
- Medicine
- Current opinion in gastroenterology
- 2018
- 10
Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe
- Medicine
- Current Gastroenterology Reports
- 2017
- 24
- PDF
Abnormal esophageal acid exposure on high‐dose proton pump inhibitor therapy is common in systemic sclerosis patients
- Medicine
- Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society
- 2018
- 8
Potential proton pump inhibitor–related adverse effects
- Medicine
- Annals of the New York Academy of Sciences
- 2020
- 2
Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden
- Medicine
- BMJ Open
- 2018
- 7
- PDF
Potential Adverse Drug Events and Nephrotoxicity Related to Prophylaxis With Omeprazole for Digestive Disorders: A Prospective Cohort Study.
- Medicine
- Clinical therapeutics
- 2018
- 2
- PDF
ACG and CAG Clinical Guideline: Management of Dyspepsia
- Medicine
- The American Journal of Gastroenterology
- 2017
- 204
Emerging dilemmas in the diagnosis and management of gastroesophageal reflux disease
- Medicine
- F1000Research
- 2017
- 6
- PDF
References
SHOWING 1-10 OF 13 REFERENCES
Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population
- Medicine
- PloS one
- 2015
- 239
- PDF
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
- Medicine
- JAMA internal medicine
- 2016
- 384
- PDF
Proton pump inhibitors and acute kidney injury: a nested case–control study
- Medicine
- BMC Nephrology
- 2013
- 70
- PDF
Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis.
- Medicine
- JAMA neurology
- 2016
- 350
- PDF
Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe
- Medicine
- Current Gastroenterology Reports
- 2017
- 24
- PDF
Abnormal esophageal acid exposure on high‐dose proton pump inhibitor therapy is common in systemic sclerosis patients
- Medicine
- Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society
- 2018
- 8
Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care Cohort.
- Medicine
- Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
- 2016
- 22
Risk of Community-Acquired Pneumonia with Outpatient Proton-Pump Inhibitor Therapy: A Systematic Review and Meta-Analysis
- Medicine
- PloS one
- 2015
- 194
- PDF
A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use
- Medicine
- Kidney international
- 2014
- 126
- PDF